Best Period to Replace or Change Plastic Stents with Self-Expandable Metallic Stents Using Multivariate Competing Risk Regression Analysis: A Single-Center Retrospective Cohort Study

Best Period to Replace or Change Plastic Stents with Self-Expandable Metallic Stents Using Multivariate Competing Risk Regression Analysis: A Single-Center Retrospective Cohort Study - The best period to replace or change plastic stent to SEMS

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000037640

Enrollment

2156

Registered

2019-08-09

Start date

2012-01-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Consecutive patients with suspected hepatobiliary-pancreatic disorders who underwent EBD attempts between January 1, 2012, and December 31, 2018, were retrospectively included in this study. Data on ERCP procedures were retrieved from the Jikei University ERCP database, with more than 6 months of follow up.

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Consecutive patients with suspected hepatobiliary-pancreatic disorders who underwent EBD attempts were retrospectively included in this study. 2. Performance status; 0,1,2. 3. More than 20 years old. 4. All patients provided written informed consent to undergo EBD

Exclusion criteria

Exclusion criteria: Opt out method was adopted, and when the patients who underwent EBD reject to enrole in this study, the data will delete. The other drainage(i.e. pancreatic duct drainage, Duodenal stent) was also excleded.

Design outcomes

Primary

Measure	Time frame
The primary endpoint of the present study was the period to recurrent biliary obstruction(PRBO) in each disease.Consecutive patients with suspected hepatobiliary-pancreatic disorders who underwent EBD attempts between January 1, 2012, and December 31, 2018, were retrospectively included in this study.	—

Secondary

Measure	Time frame
(i) comparison of the RBO factors between the benign and malignant groups; (ii) resolution of the risk factors for RBO in the benign and malignant groups; and (iii) evaluation of the risk factors in each disease.	—

Countries

Japan

Contacts

Public ContactMasafumi Chiba

The Jikei University School of Medicine Department of Endoscopy

ccl09720@gmail.com03-3433-1111(2134)

Outcome results